Stay updated on Arimoclomol in Myositis-Open Label Extension Clinical Trial
Sign up to get notified when there's something new on the Arimoclomol in Myositis-Open Label Extension Clinical Trial page.

Latest updates to the Arimoclomol in Myositis-Open Label Extension Clinical Trial page
- Check6 days agoChange DetectedA new site revision entry v3.3.2 appears in the history, replacing v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check14 days agoChange DetectedA new revision entry (v3.3.1) was added to the record history. An older revision (v3.2.0) was removed.SummaryDifference0.1%

- Check21 days agoChange DetectedA government funding lapse notice at the top of the page was removed; the rest of the study record page remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check35 days agoChange DetectedThe new screenshot shows the same record history page with identical version entries and no visible updates to the trial's core details (status, description, or eligibility). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check64 days agoChange DetectedUpdate includes a critical operating status notice and a new software version (v3.2.0), indicating updated deployment with potential service impact; previous version reference (v3.1.0) was removed.SummaryDifference11%

- Check71 days agoChange DetectedUpdated the page from revision v3.0.2 to v3.1.0 to reflect the new software version.SummaryDifference0.3%

Stay in the know with updates to Arimoclomol in Myositis-Open Label Extension Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Arimoclomol in Myositis-Open Label Extension Clinical Trial page.